How Dianthus Therapeutics Accelerates Autoimmune Therapies & Strengthens Investor Confidence
Discover how Dianthus Therapeutics is accelerating autoimmune drug development with phase‑3 milestones and investor engagement to shape the next wave of long‑acting therapies.
3 minutes to read
